Skip to main content
Advertisement
Advertisement

DYN

DYN logo

Dyne Therapeutics, Inc. Common Stock

16.58
USD
Sponsored
-0.56
-3.26%
Sep 23, 12:43 UTC -4
Open

DYN Earnings Reports

Positive Surprise Ratio

DYN beat 9 of 24 last estimates.

38%

Next Report

Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$0.92
Implied change from Q2 26 (Revenue/ EPS)
--
/
-14.81%
Implied change from Q3 25 (Revenue/ EPS)
--
/
+21.05%

Dyne Therapeutics, Inc. Common Stock earnings per share and revenue

On Jul 29, 2026, DYN reported earnings of -1.08 USD per share (EPS) for Q2 26, missing the estimate of -0.75 USD, resulting in a -42.44% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.51% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 9 analysts forecast an EPS of -0.92 USD, with revenue projected to reach -- USD, implying an decrease of -14.81% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q2 2026, Dyne Therapeutics, Inc. Common Stock reported EPS of -$1.08, missing estimates by -42.44%, and revenue of $0.00, 0% as expectations.
The stock price moved up 2.51%, changed from $25.10 before the earnings release to $25.73 the day after.
The next earning report is scheduled for Nov 02, 2026.
Based on 9 analysts, Dyne Therapeutics, Inc. Common Stock is expected to report EPS of -$0.92 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement